kneatlogo.jpg
Kneat Announces Record Revenue for Second Quarter 2024
August 06, 2024 17:17 ET | kneat.com, inc.
Kneat's Q2 2024 Growth Accelerates YoY, with Revenue up 45%, Annual Recurring Revenue up 60%, Gross Profit up 63%
Inspire_Primary_Logo_RGB_DAYLIGHT (002).png
Inspire Medical Systems, Inc. Announces Second Quarter 2024 Financial Results and Updates 2024 Outlook
August 06, 2024 16:02 ET | Inspire Medical Systems
MINNEAPOLIS, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of...
Logo.png
Global Orthopedic Splints Market to Surge Significantly at a CAGR of ~11% by 2030, | DelveInsight
August 06, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Global Orthopedic Splints Market to Surge Significantly at a CAGR of ~11% by 2030, | DelveInsight The surge in demand for orthopedic splints is...
Logo.png
Obesity Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
August 06, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Obesity Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight Obesity...
USAHS Austin Campus Celebrates a Decade of Occupational Therapy and Counteracting Industry Shortages
August 06, 2024 11:49 ET | University of St. Augustine for Health Sciences
AUSTIN, Texas, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The University of St. Augustine for Health Sciences (USAHS) is celebrating the 10-year anniversary of its Occupational Therapy (OT) program at its...
astiva logo.jpg
Astiva Health Launches Investor Relations Website, Reinforcing Commitment to Transparent Communication
August 06, 2024 09:00 ET | Astiva Health
ORANGE, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- via IBN - Astiva Health, a leader in innovative and culturally aware healthcare solutions, is pleased to announce the launch of its new Investor...
clearmindlogo.png
Clearmind Medicine: New Scientific Publication Shows MEAI's Potential as a Novel Weight Loss Drug
August 06, 2024 08:57 ET | Clearmind Medicine Inc.
Vancouver, Canada, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and...
scilogo.jpg
SciSparc’s Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article Showing MEAI Potential as a Novel Weight Loss Drug
August 06, 2024 08:57 ET | SciSparc Ltd
SciSparc has been collaborating with Clearmind Medicine to create effective treatments for obesity and metabolic syndrome by combining SciSparc’s Palmitoylethanolamide (PEA) with Clearmind’s MEAI ...
E coli Testing Market to Reach $3.9 Billion, Globally, by 2033 at 6.5% CAGR: Allied Market Research
August 06, 2024 08:44 ET | Allied Analytics LLP
Wilmington, Delaware , Aug. 06, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "E coli Testing Market by Test (Environmental Test, and Clinical Test), and End User...
STRATA Skin Sciences Logo.jpg
STRATA Skin Sciences to Participate in the 9th Annual Virtual Needham MedTech & Diagnostics 1x1 Conference
August 06, 2024 08:15 ET | STRATA Skin Sciences, Inc.
HORSHAM, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and...